May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with ...

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...

EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...

Mitochondrial mutation MT haplogroup T strongly predicts poor response to immune checkpoint inhibitors in metastatic melanoma ...

During a live event, Ahmad Tarhini, MD, PhD, and participants discussed how to use combination immunotherapy in patients with ...

Mitochondrial DNA emerges as a key factor in melanoma checkpoint inhibitor resistance, revealing new potential biomarker for patients.

DataM Intelligence | competitive Intelligence Uveal Melanoma enters a new era with novel therapies like KIMMTRAK and HEPZATO, as next-gen t ...

Josh Breen, who was diagnosed with stage 3 melanoma last year, will throw out the first pitch at Tuesday's Phillies' game as ...

A Philadelphia cancer patient will be honored at the Phillies' game on Tuesday night. Josh Breen, who was diagnosed with ...